Voltage-dependent calcium channels - Beyond dihydropyridine antagonists

Current Opinion in Pharmacology

Volumn 1, Issue 1, 2001, Pages 11-16

  Snutch, Terrance P ^a   Sutton, Kathy G ^b   Zamponi, Gerald W ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Agatoxin; Conotoxin; Gabapentin; Neuropathic pain; Nociception; Spinal cord; Voltage dependent calcium channels; Ziconotide

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ANIMAL; CHANNEL GATING; CHEMISTRY; DRUG EFFECT; ELECTROPHYSIOLOGY; HUMAN; PAIN; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; PAIN;

EID: 0035261666     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00012-1     Document Type: Review

References (50)

1. Miller RJ. Multiple calcium channels and neuronal function. Science. 235:1987;46-52.
2. Augustine GJ, Charlton MP, Smith SJ. Calcium action in synaptic transmitter release. Annu Rev Neurosci. 10:1987;633-693.
3. Janis RJ, Triggle DJ. Calcium Channels: Their Properties, Functions, Regulation and Clinical Relevance. 1991;CRC Press, London.
4. 2+ channels. Annu Rev Cell Dev Biol. 16:2000;521-555. A thorough review of the primary structure, nomenclature and molecular mechanisms of calcium channel modulation.
5. Stea A, Soong TW, Snutch TP. Voltage-gated calcium channels. Handbook on Ion Channels. 1994;113-151 CRC Press, London.
6. 1E knock-out mice. J Neurosci. 20:2000;8566-8571.
7. Vanegas H, Schaible HG. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain. 85:2000;9-18. An excellent review of the literature pertaining to the roles of calcium channels in central mechanisms of pain transmission.
8. Malmberg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci. 14:1994;4882-4890.
9. Sluka KA. Blockade of N- and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J Pharmacol Exp Ther. 287:1998;232-237.
10. 1E mutant knockout mice are viable they also exhibit altered responses to somatic inflammatory pain responses.
11. Zamponi GW. Antagonist sites of voltage-dependent calcium channels. Drug Dev Res. 42:1997;131-143.
12. Striessnig J, Hering S, Berger W, Catterall W, Glossmann H: Ca antagonist binding domains of L-type Ca channels. In Ion Channels in the Cardiovascular System: Function and Dysfunction. Edited by Spooner P. 1994:441-458.
13. Heading C. Ziconotide. Curr Opin CPNS Investigational Drugs. 1:1999;153-166. A good summary of much of the preclinical and some of the clinical data concerning Ziconotide as a potential treatment for intractable pain and brain damage following head trauma.
14. Wang YX, Pettus M, Gao M, Phillips C, Bowersox SS. Effects of intrathecal administration of Ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain. Pain. 84:2000;151-158. A solid study demonstrating that intrathecal Ziconotide is antinociceptive in a model for postoperative pain and that the effects of Ziconotide are more potent and longer lasting than morphine.
15. Ridgeway B, Wallace M, Gerayli A. Ziconotide for the treatment of severe spasticity after spinal cord injury. Pain. 85:2000;287-289.
16. Penn RD, Paice JA. Adverse effects associated with the intrathecal administration of Ziconotide. Pain. 85:2000;291-296. Several case reports illustrating that some patients experience severe adverse reactions top intrathecal Ziconotide.
17. Hu L, Ryder TR, Rafferty MF, Cody WL, Lotarski S, Mijanich GP, Millerman E, Rock DM, Song Y, Stoehr SJ, et al. N,N, dialkyl-peptidyl-amines as novel N-type Ca channel blockers. Bioorg Med Chem Lett. 9:1999;907-912. This paper identifies an entirely novel class of small organic molecule N-type calcium channel blockers.
18. Ryder TR, Hu L, Rafferty MF, Millerman E, Szoke BG, Tarczy-Hornoch K. Multiple parallel synthesis of N,N-dialkylaminepeptidylamines as N-type Ca channel blockers. Bioog Med Chem Lett. 9:1999;1813-1818.
19. Hu L, Ryder TR, Dooley DJ, Geer JJ, Lotarski SM, Milhanich GP, Milerman E, Rafferty MF, Rock DM, Stoehr SJ, et al. Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockers. Bioorg Med Chem Lett. 9:1999;1121.
20. Hu L, Ryder TR, Rafferty MF, Feng MR, Lotarski SM, Rock DM, Sinz M, Stoehr SJ, Taylor CP, Weber ML. Synthesis of a series of 4-benzyloxyaniline analogs as neuronal N-type Ca channel blockers with improved anticonvulsant and analgesic properties. J Med Chem. 42:1999;4239-4249.
21. 2+ channel blocker with oral activity for analgesia. Bioorg Med Chem Lett. 8:2000;1203-1212.
22. Fraser DD, Hoehn K, Weiss S, MacVicar BA. Aarachidonic acid inhibits sodium currents and synaptic transmission in cultures striatal neurons. Neuron. 11:1993;633-644.
23. Xiao YF, Kang JX, Morgan JP, Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 92:1995;11000-11004.
24. Leaf A. Omega-3 fatty acids and prevention of ventricular fibrillation. Prostaglandins Leukot Essent Fatty Acids. 52:1995;197-198.
25. 2+ channels in vascular smooth muscle cells. J Biol Chem. 272:1997;32240-32246.
26. Roullet J, Spaetgens RL, Burlingame T, Feng ZP, Zamponi GW. Modulation of neuronal voltage-gated Ca channels by farnesol. J Biol Chem. 274:1999;25439-25446. This paper describes a high affinity selective action of farnesol on N-type calcium channels and suggests the possibility that farnesol is an endogenous ligand for N-type channels.
27. Beedle AM, Zamponi GW. Block of voltage-dependent Ca channels by aliphatic monoamines. Biophys J. 79:2000;247-259.
28. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
29. Nicholson B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand. 101:2000;359-371. Good overall review describing mechanisms involved in the development of neuropathic pain, use of Gabapentin in animal models of pain and summarizing recent clinical trials.
30. Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clin Ter. 151:2000;145-148.
31. McClelland D, Herd MB, Martin DJ, Sutton KG, Lee K, Scott RH. Comparisons between responses evoked by GABA receptor mechanisms and gabapentin in cultured neonatal rat dorsal root ganglion neurones. J Physiol. 528P:2000;C53.
32. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 271:1996;768-776.
33. 2δ immunoreactivity in the spinal cord of the rat following chronic constriction injury of the sciatic nerve. Br Neurosci Assoc Abstr 1999, 15:46.08.
34. 2δ binding activity of stereo-specific gabapentin analogues is shown to correlate with their analgesic action in animal models of neuropathic pain.
35. 2+ channels: role in channel function. Trends Neurosci. 21:1998;148-154.
36. Klugbauer N, Lacinova L, Marais E, Hobom M, Hofmann F. Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci. 19:1999;684-691.
37. Stefani A, Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 37:1998;83-91.
38. Rock DM, Kelly KM, Macdonald RL. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 16:1993;89-98.
39. 2+ influx into cultured rat dorsal root ganglion neurones and F11 neuroblastoma cells. J Physiol. 528:2000;PC45.
40. Sutton KG, Scott RH, Lee K, Pinnock RD: Gabapentin inhibits high threshold calcium channel currents in cultured rat dorsal root ganglia neurones. Soc Neurosci Abstr 2000, 26:234.4.
41. Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, Lee K. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br J Pharmacol. 130:2000;1731-1734. This paper presents evidence for a presynaptic site of action for gabapentin, which is dependent upon the hyperalgesic state of the animal.
42. Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain. 85:2000;405-414.
43. Meder WP, Dooley DJ. Modulation of K+-induced synaptosomal calcium influx by gabapentin. Brain Res. 875:2000;157-159.
44. 2+ influxby gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Brit J Pharmacol. 130:2000;900-906. This paper provides evidence for gabapentin-dependent functional change in neuronal signal transmission processing. Data is presented showing gabapentin inhibition of presynaptic voltage-gated Ca influx and a reduction in neurotransmitter release.
45. Chizh BA, Scheede M, Schultz H. Antinociception and (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol. 362:2000;197-200.
46. Stringer JL, Taylor CP. The effects of gabapentin in the rat hippocampus are mimicked by two structural analogs, but not by nimodipine. Epilepsy Res. 41:2000;155-162.
47. Schumacher TB, Beck H, Steinhauser C, Schramm J, Elger CE. Effects of phenytoin, carbamazepine and gabapentin on calcium currents in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia. 39:1998;355-363.
48. Su T, Lunney E, Campbell G, Oxender DL. Transport of gabapentin, a γ-amino acid drug, by system L α-amino acid transporters: a comparative study in astrocytes, synaptosomes and CHO cells. J Neurochem. 64:1995;2125-2131.
49. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epiliepsy. Ann Neurol. 39:1996;95-99.
50. Honmou O, Oyelese AA, Kocsis D. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res. 692:1995;273-277.